Medicine Details
Brand name – Imbruvica
Generic name – Ibrutinib
Salt composition – Ibrutinib
Manufacturer – Janssen Biotech
Dosage form – Capsule
Packaging – Bottle
Indication – Leukemia
Strength – 140mg
Storage – Store at room temperature 20°C to 25°C.
Prescription required – Yes
Uses Of Imbruvica
Imbruvica 140mg Capsule (Ibrutinib) is used in the treatment of:
- Mantle cell lymphoma (MCL)
- Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)
- Waldenström’s macroglobulinemia (WM)
- Marginal zone lymphoma (MZL)
- Chronic graft versus host disease (GVHD)
- The active ingredient of the Imbruvica 140 mg capsule is Ibrutinib. It is a small-molecule inhibitor of BTK.
Pharmacodynamics
Ibrutinib is a small-molecule inhibitor of BTK. It forms a covalent bond with a cysteine residue in the BTK active site and then leads to inhibition of BTK enzymatic activity. BTK is a signaling molecule of the B-cell antigen receptor (BCR) and cytokine receptor pathways. Nonclinical studies suggest that ibrutinib works to inhibit malignant B-cell proliferation and survival in vivo along with cell migration and substrate adhesion in vitro.


